Co-Diagnostics, Inc.
NASDAQ:CODX
1.21 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.991 | 34.218 | 97.886 | 74.553 | 0.215 | 0.04 | 0.008 | 0 | 0.01 | 0 |
| Cost of Revenue
| 5.415 | 5.481 | 11.575 | 16.591 | 0.112 | 0.009 | 0 | 0.037 | 0.043 | 0 |
| Gross Profit
| -4.424 | 28.737 | 86.311 | 57.961 | 0.103 | 0.031 | 0.007 | -0.037 | -0.033 | 0 |
| Gross Profit Ratio
| -4.462 | 0.84 | 0.882 | 0.777 | 0.477 | 0.765 | 0.961 | 0 | -3.314 | 0 |
| Reseach & Development Expenses
| 22.963 | 17.438 | 14.962 | 3.185 | 1.371 | 1.361 | 1.003 | 0.731 | 0.807 | 0.311 |
| General & Administrative Expenses
| 14.279 | 14.263 | 11.551 | 8.279 | 3.497 | 3.571 | 3.096 | 0.797 | 0.847 | 0.483 |
| Selling & Marketing Expenses
| 6.861 | 7.345 | 13.398 | 4.665 | 1.062 | 1.166 | 0.427 | 0.122 | 0.281 | 0.227 |
| SG&A
| 21.14 | 21.608 | 24.948 | 12.944 | 4.559 | 4.736 | 3.523 | 0.919 | 1.128 | 0.709 |
| Other Expenses
| 22.963 | 1.283 | 0.335 | 0.139 | 0.066 | 0.051 | 0.046 | 0 | 0.043 | 0 |
| Operating Expenses
| 44.103 | 40.328 | 40.246 | 16.268 | 5.996 | 6.148 | 4.571 | 1.688 | 1.978 | 1.034 |
| Operating Income
| -48.527 | -11.591 | 46.065 | 41.694 | -5.894 | -6.118 | -4.564 | -1.688 | -1.968 | -1.034 |
| Operating Income Ratio
| -48.944 | -0.339 | 0.471 | 0.559 | -27.416 | -153.286 | -595.676 | 0 | -196.798 | 0 |
| Total Other Income Expenses Net
| 10.416 | -7.256 | -0.429 | 0.875 | -0.302 | -0.039 | -2.089 | -0.241 | -0.075 | -0.014 |
| Income Before Tax
| -38.111 | -18.847 | 45.636 | 42.569 | -6.196 | -6.272 | -6.959 | -1.929 | -2.043 | -1.048 |
| Income Before Tax Ratio
| -38.438 | -0.551 | 0.466 | 0.571 | -28.82 | -157.143 | -908.279 | 0 | -204.317 | 0 |
| Income Tax Expense
| -2.778 | -4.609 | 8.977 | 0.091 | -0.126 | -0.019 | 0.294 | 0 | 0 | 0 |
| Net Income
| -35.333 | -14.238 | 36.659 | 42.479 | -6.069 | -6.272 | -6.959 | -1.929 | -2.043 | -1.048 |
| Net Income Ratio
| -35.637 | -0.416 | 0.375 | 0.57 | -28.232 | -157.143 | -908.279 | 0 | -204.317 | 0 |
| EPS
| -1.2 | -0.45 | 1.27 | 1.59 | -0.36 | -0.5 | -0.63 | -0.17 | -0.18 | -0.13 |
| EPS Diluted
| -1.2 | -0.45 | 1.23 | 1.52 | -0.36 | -0.5 | -0.63 | -0.17 | -0.18 | -0.13 |
| EBITDA
| -47.296 | -2.682 | 46.445 | 42.708 | -6.024 | -6.086 | -4.531 | -1.65 | -1.925 | -1.021 |
| EBITDA Ratio
| -47.703 | -0.078 | 0.474 | 0.573 | -28.022 | -152.49 | -591.344 | 0 | -192.484 | 0 |